Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Probiotic Visbiome for Inflammation and Translocation in HIV II (PROOV IT II)

NCT02441231 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT02441231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02441231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Probiotic Visbiome for Inflammation and Translocation in HIV II (PROOV IT II)
Lead sponsor
University Health Network, Toronto
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2015
Completion date
May 31, 2019
Enrollment
36 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1 infection